Literature DB >> 6262098

The efficacy of some bis-pyridinium oximes as antidotes to soman in isolated muscles of several species including man.

O Wolthuis, R A Vanwersch, H J Van der Wiel.   

Abstract

Previous results had shown that bis-pyridinium oximes, particularly HI-6 are quite effective therapeutically in soman-poisoned rats and mice in vivo and in the rat diaphragm preparation in vitro. The aim of the present study was to investigate the efficacy of bis-pyridinium oximes on soman-inhibited neuromuscular transmission in muscle preparations from several species including man. The muscles tested were preparations of rat diaphragm and intercostal muscle, guinea-pig diaphragm, dog external intercostal muscle and human external interscotal muscle. These muscles were stimulated indirectly with field stimulation. With a few exceptions the preparations were exposed to soman for 2.5 or 15 min. In some cases different exposure times were employed or the organophosphate sarin was administered instead of its analogue soman. After the degree of inhibition of neuromuscular transmission had been established, oximes were added to the bath fluid. After washout 15 min later, recovery of neuromuscular transmission was tested. Subsequently, a second dose of soman was administered to investigate whether the recovery observed had been caused by cholinesterase reactivation. The results of these experiments indicate that the oximes tested, mostly HI-6, were quite effective as soman antidotes in muscle preparations of rats, guinea-pigs and dogs. In the human preparation while these oximes were quite effective after sarin intoxication they were essentially without effect against soman.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262098     DOI: 10.1016/0014-2999(81)90169-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Neuromuscular effects of candoxin, a novel toxin from the venom of the Malayan krait (Bungarus candidus).

Authors:  S Nirthanan; E Charpantier; P Gopalakrishnakone; M C E Gwee; H E Khoo; L S Cheah; R M Kini; D Bertrand
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

2.  Therapy of organophosphate poisoning in the rat by direct effects of oximes unrelated to ChE reactivation.

Authors:  H P van Helden; J de Lange; R W Busker; B P Melchers
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

3.  HI-6 therapy of soman and tabun poisoning in primates and rodents.

Authors:  M G Hamilton; P M Lundy
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

4.  Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro.

Authors:  J E Tattersall
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

5.  Pharmacokinetics of the oximes HI 6 and HLö 7 in dogs after i.m. injection with newly developed dry/wet autoinjectors.

Authors:  U Spöhrer; H Thiermann; R Klimmek; P Eyer
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

6.  HLö 7 dimethanesulfonate, a potent bispyridinium-dioxime against anticholinesterases.

Authors:  P Eyer; I Hagedorn; R Klimmek; P Lippstreu; M Löffler; H Oldiges; U Spöhrer; I Steidl; L Szinicz; F Worek
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

7.  Mechanism of action of HI-6 on soman inhibition of acetylcholinesterase in preparations of rat and human skeletal muscle; comparison to SAD-128 and PAM-2.

Authors:  Z Grubic; A Tomazic
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

8.  Studies on the stability and decomposition of the Hagedorn-oxime HLö 7 in aqueous solution.

Authors:  P Eyer; B Ladstetter; W Schäfer; J Sonnenbichler
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

9.  Treatment of tabun poisoned guinea-pigs with atropine, HLö 7 or HI 6: effect on respiratory and circulatory function.

Authors:  F Worek; T Kirchner; L Szinicz
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

10.  Comparison of the therapeutic effects and pharmacokinetics of HI-6, HLö-7, HGG-12, HGG-42 and obidoxime following non-reactivatable acetylcholinesterase inhibition in rats.

Authors:  H P van Helden; H J van der Wiel; J J Zijlstra; B P Melchers; R W Busker
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.